[
1. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5): 373384.10.1038/ni.186320404851
]Search in Google Scholar
[
2. Loganathan R, Nazeer M, Goda V, Devaraju P, Ali M, Karunakaran P, et al. Genetic variants of TLR4 and TLR9 are risk factors for chronic Helicobacter pylori infection in South Indian tamils. Hun Immunoy. 2017;78(2):216220.10.1016/j.humimm.2016.12.00227993530
]Search in Google Scholar
[
3. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5(10):987995.10.1038/ni111215454922
]Search in Google Scholar
[
4. So WY and Ouchi T. The application of Toll like receptors for cancer therapy. Int J Biol Sci. 2010;6(7):675681.
]Search in Google Scholar
[
5. Wang Q, Zhang X, Xiao T, Pan C, Liu X, Zhao Y. Prognostic role of Toll-like receptors in cancer: a meta-analysis. Ther Clin Risk Manag. 2018;14:1323330.10.2147/TCRM.S171341607164430104878
]Search in Google Scholar
[
6. González-Reyes S, Marín L, González L, González LO, del Casar JM, Lamelas ML, et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer. 2010;10:665.10.1186/1471-2407-10-665300968021129170
]Search in Google Scholar
[
7. Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe. 2014;15(3):266–82.10.1016/j.chom.2014.02.011399224324629334
]Search in Google Scholar
[
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.10.3322/caac.2010721296855
]Search in Google Scholar
[
9. Zauner L, Nadal D. Understanding TLR9 action in Epstein-Barr virus infection. Front Biosci (Landmark Ed).2012;17:1219–31.10.2741/398222201799
]Search in Google Scholar
[
10. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235(2):323333.10.1002/path.4448428067625251730
]Search in Google Scholar
[
11. Liu S, Wang X, Shi Y, Han L, Zhao Z, Zhao Cd at al. Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China. Saudi J Gastroenterol. 2015;21(2):95–103.10.4103/1319-3767.153832439258225843196
]Search in Google Scholar
[
12. Tobouti PL, Bolt R, Radhakrishnan R, Machado de Sousa SCOd Hunter KD. Altered Toll-like receptor expression and function in HPV-associated oropharyngeal carcinoma. Oncotarget. 2018;9(1):236248.10.18632/oncotarget.18959578746129416610
]Search in Google Scholar
[
13. Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol. 2014;26:99–115.10.1016/j.semcancer.2014.04.00424751797
]Search in Google Scholar
[
14. Ruuskanen M, Leivo I, Minn H, Vahlberg T, Haglund C, Hagström J, et al. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma. BMC Cancer. 2019;19(1):624.10.1186/s12885-019-5816-9659360231238894
]Search in Google Scholar
[
15. Aggarwal R, Misra S, Guleria C, Suri V, Mangat N, Sharma M, et al. Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: a case-control study. Gynecol Oncol. 2015;138(2):358–62.10.1016/j.ygyno.2015.05.02926024767
]Search in Google Scholar
[
16. Rich AM, Hussaini HM, Parachuru VPB, and Seymour GJ. Toll-like receptors and cancer, particularly oral squamous cell carcinoma. Fronn Immunol. 2014;5:464.10.3389/fimmu.2014.00464417411625309546
]Search in Google Scholar
[
17. Shi Y, Peng SL, Yang LF, Chen X, Tao YG, Cao Y. Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chin J Cancer. 2016;35:16.10.1186/s40880-016-0079-1472412326801987
]Search in Google Scholar
[
18. Sharma U, Singhal P, Bandil K, Patle R, Kumar A, Neyaz KD et al. Genetic variations of TLRs and their association with HPV/EBV, co-infection along with nicotine exposure in the development of premalignant/malignant lesions of the oral cavity in Indian population. Cancer Epidemiol. 2019;61:38–49.10.1016/j.canep.2019.05.00331129425
]Search in Google Scholar
[
19. Barros MR, de Oliveira THA, de Melo CML, Venuti Ad de Freitas AC. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers. J Immunol Res. 2018.10.1155/2018/2912671595492129854832
]Search in Google Scholar
[
20. Smith M, García-Martínez E, Pitter M, Fucikova J, Spisek R, Zitvogel Ld et al. Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology. 2018;7(12):1–15.10.1080/2162402X.2018.1526250627932530524908
]Search in Google Scholar
e 